Johan Lund
Directeur/Membre du Conseil chez OLINK HOLDING AB
Fortune : 2 M $ au 30/06/2024
Profil
Johan Lund is the founder of Kynexis Medicine Development AB, where he is currently the Chief Executive Officer since 2018.
He is also the founder of Harden Pharmacy LLC.
Dr. Lund's current positions include Chairman at Aqilion AB since 2018, Chairman at Neogap Therapeutics AB, Director at Genagon Therapeutics AB since 2019, Director at Tcer AB since 2019, Director at Pelago Bioscience AB, and Independent Non-Executive Director at Olink Holding AB since 2020.
Dr. Lund's former positions include Professor & Chairman-Anatomy & Cell at the University of Bergen, Independent Director at LIDDS AB, VP, Head-Immunology & Inflammation at Celgene Corp.
from 2016 to 2017, Chief Scientific Officer & Senior Vice President at Pfizer Inc. from 2012 to 2015, VP-Respiratory & Inflammation Research at AstraZeneca AB, Associate Professor at Karolinska Institutet, and Managing Partner at J Lund & Associates, LLC from 2015 to 2016.
Dr. Lund's education includes undergraduate and doctorate degrees from Karolinska Institutet.
Dr. Lund is also the founder of Harden Pharmacy LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OLINK HOLDING AB
0,05% | 05/02/2024 | 60 703 ( 0,05% ) | 2 M $ | 30/06/2024 |
Postes actifs de Johan Lund
| Sociétés | Poste | Début |
|---|---|---|
| OLINK HOLDING AB | Directeur/Membre du Conseil | 01/12/2020 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/05/2019 |
| Kynexis Medicine Development AB | Directeur Général | 01/08/2018 |
| Tcer AB | Directeur/Membre du Conseil | 01/06/2019 |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Président | 12/06/2018 |
Neogap Therapeutics AB
 Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden. | Président | - |
Pelago Bioscience AB
 Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement. | Directeur/Membre du Conseil | - |
Anciens postes connus de Johan Lund
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/05/2017 |
| J Lund & Associates, LLC | Corporate Officer/Principal | 01/03/2016 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Johan Lund
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| OLINK HOLDING AB | Health Technology |
| PFIZER, INC. | Health Technology |
| LIDDS AB | Health Technology |
| Entreprise privées | 10 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Kynexis Medicine Development AB | |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| J Lund & Associates, LLC | |
| Tcer AB | |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
Neogap Therapeutics AB
Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden. | Commercial Services |
Pelago Bioscience AB
Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement. | Commercial Services |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Harden Pharmacy LLC |
